Abstract:Background FFA1 is abundantly expressed in the liver, skeletal muscle, monocytes and nervous system, but is particularly abundant in pancreatic β cells. It is widely believed that FFA1 exerts its regulatory roles in a variety of physiological and pathological functions. In response to oleic acid, FFA1 has been shown to induce the activation of extracellular signal-regulated kinase 1 and 2 (ERK1/2) through a mechanism involving EGFR transactivation in a breast cancer cell line. However, the underlying molecular mechanism for ERK1/2 activation mediated by n-6 free fatty acid (LA) in HEK293 cells remains to be further elucidated. Methods A FLAG-FFA1 vector was stably expressed in HEK293 cells. Western blot analysis was applied to investigate the change in LA-induced ERK1/2 phosphorylation change in response to kinase inhibitors. Arrestin-2/3-specific siRNA was used to analyze the effect of arrestin-2/3 knockdown on FFA1-mediated ERK1/2 activation. Results We proved that activation of ERK1/2 by LA was rapid, peaking at 5 min. Further experiments proved that FFA1 couples to a Gq protein and activates PI-PLC, which induces the IP3/Ca 2+ and DAG/PKC signal pathways, both of which are involved in ERK1/2 activation. We also showed that there is no EGFR transactivation, arrestin-2/3 or Gβγ pathway participation in ERK1/2 phosphorylation. Treating cells with PTX abolished ERK1/2 activation at a late time point (≥20 min), indicating a critical role for Gi subunits in FFA1-mediated ERK1/2 activation. Conclusions Our study provides a detailed delineation of the LA-mediated activation of ERK1/2 in HEK293 cells that are stably transfected with human FFA1. We also present evidence of Gi/Gq-induced synergism in the regulation of ERK1/2 phosphorylation. These observations may provide new insights into the pharmacological effects of FFA1 and the physiological functions modulated by FFA1-mediated activation of ERK1/2.

Molecular recognition and activation mechanism of short-chain fatty acid receptors FFAR2/3

Chemogenetic analysis of how receptors for short chain fatty acids regulate the gut-brain axis

Structural basis of omega-3 fatty acid receptor FFAR4 activation and G protein coupling selectivity

Agonist-induced activation of human FFA1 receptor signals to extracellular signal-regulated kinase 1 and 2 through Gq- and Gi-coupled signaling cascades

Structural insights into endogenous ligand selectivity and activation mechanisms of FFAR1 and FFAR2

Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2

Synthesis, Activity, and Docking Study of Novel Phenylthiazole-Carboxamido Acid Derivatives as FFA2 Agonists

Short‐chain Fatty Acids Regulate B Cells Differentiation Via the FFA2 Receptor to Alleviate Rheumatoid Arthritis

The Single-cell Atlas of Short-chain Fatty Acid Receptors in Human and Mice Hearts

Structural basis for the ligand recognition and signaling of free fatty acid receptors

Discovery of novel FFA4 (GPR120) receptor agonists with β-arrestin2-biased characteristics

Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2

Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84

Short-Chain Fatty Acid and FFAR2 Activation - A New Option for Treating Infections?

Addressing free fatty acid receptor 1 (FFAR1) activation using supervised molecular dynamics

Long Chain Fatty Acids as Modulators of Immune Cells Function: Contribution of FFA1 and FFA4 Receptors

FFA4 Receptor (GPR120): A Hot Target for the Development of Anti-Diabetic Therapies.

Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release

Sensing unsaturated fatty acids: insights from GPR120 signaling

Identification and characterization of the free fatty acid receptor 2 (FFA2) and a novel functional FFA2-like receptor (FFA2L) for short-chain fatty acids in pigs: evidence for the existence of a duplicated FFA2 gene (FFA2L) in some mammalian species

Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism